TABLE 2

Clinical course of patients with isolation of Mycobacterium simiae

Patient	Sex	Age years	Disposition	Clinical manifestation	Pulmonary radiology	ATS criteria fulfilled	Other NTM species	NTM therapy	Outcome
P1	m	37	CF	Pulmonary	Bronchiectasis, nodular changes	y	M. chimaera	Clarithromycin, moxifloxacin, clofazimine, cotrimoxazole	Culture conversion, alive
P2	m	70	Malignoma	Pulmonary	Bronchiectasis, malignoma	n	NA	n	Culture conversion, alive
P3	m	78	Malignoma	Pulmonary	Infiltration, pleural effusion	n	NA	n	Alive
P4	m	63	SLD (emphysema, bronchiectasis)	Pulmonary	Bronchiectasis, carnificating pneumonia	n	NA	n	Alive
P5	f	36	CF	Pulmonary	Bronchiectasis	y	M. abscessus, M. intracellulare, M. chelonae	Clarithromycin, levofloxacin, linezolid	Culture conversion, alive
P6	m	36	CF	Pulmonary	Bronchiectasis, infiltration	n	M. abscessus	n	Culture conversion, alive
P7	f	41	HIV CDC Stadium C3	Disseminated	Slight emphysema	NA	NA	Clarithromycin/azithromycin, ethambutol, rifabutin, levofloxacin, cotrimoxazole	Culture conversion, alive

NTM: non-tuberculous mycobacterium; P: patient; CF: cystic fibrosis; SLD: structural lung disease; CDC: Centers for Disease Control and Prevention; NA: not applicable; m: male; f: female; y: yes; n: no.